CD44 and thyroid tumor: Some internal validations emerged, such as the pairs PLAU/PLAUR, SPP1/CD44, and SPP1/ITGA9, whose ligands have been demonstrated overexpressed in thyroid tumors [12], [13] as well as in our in vitro model [6].